1. Home
  2. UTL vs ARDX Comparison

UTL vs ARDX Comparison

Compare UTL & ARDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo UNITIL Corporation

UTL

UNITIL Corporation

N/A

Current Price

$53.17

Market Cap

906.9M

Sector

Utilities

ML Signal

N/A

Logo Ardelyx Inc.

ARDX

Ardelyx Inc.

N/A

Current Price

$3.37

Market Cap

975.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
UTL
ARDX
Founded
1984
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Power Generation
Biotechnology: Pharmaceutical Preparations
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
906.9M
975.9M
IPO Year
1995
2014

Fundamental Metrics

Financial Performance
Metric
UTL
ARDX
Price
$53.17
$3.37
Analyst Decision
Buy
Strong Buy
Analyst Count
2
7
Target Price
$56.50
$15.14
AVG Volume (30 Days)
85.8K
3.6M
Earning Date
05-04-2026
04-30-2026
Dividend Yield
3.65%
N/A
EPS Growth
1.37
N/A
EPS
2.11
N/A
Revenue
$536,000,000.00
$2,607,000.00
Revenue This Year
$5.43
$37.75
Revenue Next Year
$4.22
$34.24
P/E Ratio
$24.87
N/A
Revenue Growth
8.33
N/A
52 Week Low
$45.17
$3.56
52 Week High
$57.26
$8.40

Technical Indicators

Market Signals
Indicator
UTL
ARDX
Relative Strength Index (RSI) 39.79 21.27
Support Level $52.10 N/A
Resistance Level $53.80 $3.92
Average True Range (ATR) 0.99 0.12
MACD -0.14 0.01
Stochastic Oscillator 20.25 2.80

Price Performance

Historical Comparison
UTL
ARDX

About UTL UNITIL Corporation

Unitil Corp through its subsidiaries engages in the distribution of electricity and natural gas in its service territories in the states of New Hampshire, Massachusetts and Maine. Its natural gas operations include gas distribution utility operations and interstate gas transmission pipeline operations. It also engages in interstate natural gas transmission pipeline company, operating approximately 85 miles of underground gas transmission pipeline located in Maine and New Hampshire. The company's segments include Electric and Gas.

About ARDX Ardelyx Inc.

Ardelyx Inc is a biopharmaceutical company developing and commercialize, first-in-class medicines that meet unmet medical needs. It has developed a platform that enabled the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. Its products Tenapanor, branded as IBSRELA, is used for the treatment of adults with IBS-C. Tenapanor, branded as XPHOZAH, is used to reduce serum phosphorus in adults with CKD on dialysis as add-on therapy in patients who have an inadequate response to phosphate binders or who are intolerant of any dose of phosphate binder therapy.

Share on Social Networks: